Template:Available_forms_of_estradiol

Template:Available forms of estradiol

More information Route, Ingredient ...

Share this article:

This article uses material from the Wikipedia article Template:Available_forms_of_estradiol, and is written by contributors. Text is available under a CC BY-SA 4.0 International License; additional terms may apply. Images, videos and audio are available under their respective licenses.

[1] This table includes primarily products available as a single-ingredient estradiol preparation—thus excluding compounds with progestogens or other ingredients included. The table furthermore does not include compounded drugs—only commercially produced products. Availability of each product varies by country.

[2] Doses are given per unit (ex: per tablet, per mL).

[3] Other brand names may be manufactured or previously manufactured.

[4] By intramuscular or subcutaneous injection.

[Drugs@FDA-estdose-5] [1]
"Drugs@FDA: FDA Approved Drug Products". United States Food and Drug Administration. Retrieved 26 July 2018.

[Lobo_2007-6] [2]
Lobo RA (5 June 2007). Treatment of the Postmenopausal Woman: Basic and Clinical Aspects. Academic Press. pp. 177, 217–226, 770–771. ISBN 978-0-08-055309-2.

[FalconeHurd2017-7] [3]
Falcone T, Hurd WW (14 June 2017). Clinical Reproductive Medicine and Surgery: A Practical Guide. Springer. pp. 179–. ISBN 978-3-319-52210-4.

[Becker_2001-8] [4]
Becker KL (2001). Principles and Practice of Endocrinology and Metabolism. Lippincott Williams & Wilkins. pp. 889, 1059–1060, 2153. ISBN 978-0-7817-1750-2.

[KleemannEngel2014-9] [5]
Kleemann A, Engel J, Kutscher B, Reichert D (14 May 2014). Pharmaceutical Substances, 5th Edition, 2009: Syntheses, Patents and Applications of the most relevant APIs. Thieme. pp. 1167–1174. ISBN 978-3-13-179525-0.

[Muller1998-10] [6]
Muller (19 June 1998). European Drug Index: European Drug Registrations, Fourth Edition. CRC Press. pp. 276, 454–455, 566–567. ISBN 978-3-7692-2114-5.

[KrishnaShah1996-11] [7]
Krishna UR, Sheriar NK (1996). Menopause. Orient Blackswan. pp. 70–. ISBN 978-81-250-0910-8.

[NNR1949-12] [8]
"NNR: Products Recently Accepted by the A. M. A. Council on Pharmacy and Chemistry". Journal of the American Pharmaceutical Association (Practical Pharmacy ed.). 10 (11): 692–694. 1949. doi:10.1016/S0095-9561(16)31995-8. ISSN 0095-9561.

[AerodiolLabel-13] [9]
"AERODIOL (Oestradiol hemihydrate 150 micrograms/actuation)" (PDF). Servier Laboratories (Aust) Pty Ltd.

[Drugs.com-14] [10]
"Estradiol". Drugs.com.

[pmid18382901-15] [11]
Sahin FK, Koken G, Cosar E, Arioz DT, Degirmenci B, Albayrak R, Acar M (2008). "Effect of Aerodiol administration on ocular arteries in postmenopausal women". Gynecol. Endocrinol. 24 (4): 173–7. doi:10.1080/09513590701807431. PMID 18382901. 300 μg 17β-estradiol (Aerodiol®; Servier, Chambrayles-Tours, France) was administered via the nasal route by a gynecologist. This product is unavailable after March 31, 2007 because its manufacturing and marketing are being discontinued.

[PlouffeRavnikar2012-16] [12]
Plouffe Jr L, Ravnikar VA, Speroff L, Watts NB (6 December 2012). Comprehensive Management of Menopause. Springer Science & Business Media. pp. 271–. ISBN 978-1-4612-4330-4.

[UC1952-17] [13]
University of California (1868-1952) (1952). Hospital Formulary and Compendium of Useful Information. University of California Press. pp. 49–. GGKEY:2UAAZRZ5LN0.{{cite book}}: CS1 maint: numeric names: authors list (link)

[Leidenberger2013-18] [14]
Leidenberger FA (17 April 2013). Klinische Endokrinologie für Frauenärzte. Springer-Verlag. pp. 527–. ISBN 978-3-662-08110-5.

[lower-alpha 1]

[lower-alpha 2]

[lower-alpha 3]

[lower-alpha 4]

[1]

[2]

[3]

[4]

[5]

[6]

[7]

[8]

[9]

[10]

[11]

[12]

[13]

[14]

Route	Ingredient	Form	Dose^{[lower-alpha 2]}	Brand names^{[lower-alpha 3]}
Oral	Estradiol	Tablet	0.1, 0.2, 0.5, 1, 2, 4 mg	Estrace, Ovocyclin
Oral	Estradiol valerate	Tablet	0.5, 1, 2, 4 mg	Progynova
Transdermal	Estradiol	Patch	14, 25, 37.5, 50, 60, 75, 100 µg/d	Climara, Vivelle
		Gel pump	0.06% (0.52, 0.75 mg/pump)	Elestrin, EstroGel
		Gel packet	0.1% (0.25, 0.5, 1.0 mg/pk.)	DiviGel, Sandrena
		Emulsion	0.25% (25 µg/pouch)	Estrasorb
		Spray	1.53 mg/spray	Evamist, Lenzetto
Vaginal	Estradiol	Tablet	10, 25 µg	Vagifem
		Cream	0.01% (0.1 mg/gram)	Estrace
		Insert	4, 10 µg	Imvexxy
		Ring	2 mg/ring (7.5 µg/d, 3 mon.)	Estring
	Estradiol acetate	Ring	50, 100 µg/d, 3 months	Femring
Injection^{[lower-alpha 4]}	Estradiol	Microspheres	1 mg/mL	Juvenum E
	Estradiol benzoate	Oil solution	0.167, 0.2, 0.333, 1, 1.67, 2, 5, 10, 20, 25 mg/mL	Progynon-B
	Estradiol cypionate	Oil solution	1, 3, 5 mg/mL	Depo-Estradiol
	Estradiol valerate	Oil solution	5, 10, 20, 40 mg/mL	Progynon Depot
Implant	Estradiol	Pellet	20, 25, 50, 100 mg, 6 mon.	Estradiol Implants
Notes and sources: This table includes primarily products available as a single-ingredient estradiol preparation—thus excluding compounds with progestogens or other ingredients included. The table furthermore does not include compounded drugs—only commercially produced products. Availability of each product varies by country. Doses are given per unit (ex: per tablet, per mL). Other brand names may be manufactured or previously manufactured. By intramuscular or subcutaneous injection. Sources: ^[1]^[2]^[3]^[4]^[5]^[6]^[7]^[8]^[9]^[10]^[11]^[12]^[13]^[14]

Template:Available_forms_of_estradiol

Template:Available forms of estradiol

See also

References

Share this article: